Ping An Healthcare And Technology (SEHK:1833) Back In Focus After AI Debut But Is It Fully Valued

Ping An Healthcare and Technology (SEHK:1833) is back in focus after parent Ping An Insurance showcased new artificial intelligence tools in healthcare, insurance, and payments at the World Artificial Intelligence Conference 2026.

See our latest analysis for Ping An Healthcare and Technology.

At a share price of HK$7.65, Ping An Healthcare and Technology has seen short term momentum fade, with the 90 day share price return down 32.24% and the year to date share price return down 47.53%, even though the 3 year total shareholder return is positive at 9.22%.

If the AI push in healthcare has caught your attention, it could be a good moment to look across the sector and review 130 healthcare AI stocks

Ping An Healthcare and Technology now combines a growing online healthcare platform with a share price that has retreated sharply in recent months. How does that mix translate into what investors are currently paying for the stock?

Price-to-Earnings of 37x: Is it justified?

At HK$7.65, Ping An Healthcare and Technology is currently valued at a P/E of 37x, which screens as expensive relative to both peers and an estimated fair level.

The P/E multiple compares what investors are paying today for each unit of current earnings. For a company like Ping An Healthcare and Technology, operating an online healthcare platform in China, this figure often reflects how the market views its earnings growth profile and the stability of its profitability.

Here, the current P/E of 37x sits above the estimated fair P/E of 16x and above the peer average of 33.1x. That suggests investors are paying a premium that is meaningfully higher than the level our fair ratio implies the market could eventually move towards, and also higher than the broader Asian Consumer Retailing industry average P/E of 15.2x.

Explore the SWS fair ratio for Ping An Healthcare and Technology

Result: Price-to-Earnings of 37x (OVERVALUED)

However, Ping An Healthcare and Technology still faces risks if revenue growth slows from its recent 10.58% rate, or if profitability trends reverse from current net income levels.

Find out about the key risks to this Ping An Healthcare and Technology narrative.

Another view: what our DCF model says about Ping An Healthcare and Technology

While the 37x P/E ratio makes Ping An Healthcare and Technology look expensive, the SWS DCF model points the other way. With the stock at HK$7.65 versus an estimated future cash flow value of HK$18.90, it screens as heavily undervalued on this approach.

This kind of gap can signal either a pricing opportunity or a sign that the cash flow assumptions are too optimistic. It is worth asking which side of the story you find more convincing, the earnings multiple or the cash flow view.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ping An Healthcare and Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 235 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals around Ping An Healthcare and Technology can make the picture feel unclear. Take a moment to review the data, weigh the concerns and positives, and see the full breakdown of 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Ping An Healthcare and Technology?

If Ping An Healthcare and Technology has sharpened your focus on valuation and risk, it makes sense to widen your watchlist with a few targeted, data driven stock ideas.

• Spot potential bargains early by scanning 235 high quality undervalued stocks that combine pricing appeal with solid underlying fundamentals.
• Build a portfolio with staying power by reviewing the solid balance sheet and fundamentals stocks screener (421 results) that may better handle tough conditions.
• Aim for smoother returns by checking out 293 resilient stocks with low risk scores that score well on financial strength and volatility metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com